Astellas Pharma Inc 2014 SR
The report outlines Astellas Pharma's environmental performance for fiscal 2013, focusing on global warming, biodiversity, and resource recycling. Key achievements include a 26.5% reduction in global greenhouse gas emissions compared to the 2005 base year and reaching a biodiversity index of 2.27 times the base level. The company also maintained a zero-emission status in Japan with a landfill rate of 0.9%. Strategic investments were made in energy-efficient technologies and renewable energy sources like wind and biomass.
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2014
Type: SR
Pages: 39
Back to company
Astellas Pharma Inc
Environment Report
The report outlines Astellas Pharma's environmental performance for fiscal 2013, focusing on global warming, biodiversity, and resource recycling. Key achievements include a 26.5% reduction in global greenhouse gas emissions compared to the 2005 base year and reaching a biodiversity index of 2.27 times the base level. The company also maintained a zero-emission status in Japan with a landfill rate of 0.9%. Strategic investments were made in energy-efficient technologies and renewable energy sources like wind and biomass.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Jan 1, 2013 - Mar 31, 2014
Fiscal Year
2014
Published
Jun 1, 2014
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Employees